[HTML][HTML] An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Journal of …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has
become a pandemic worldwide with mortality of millions. Nanotechnology can be used to …

[HTML][HTML] Liposomes as adjuvants and vaccine delivery systems

DS Tretiakova, EL Vodovozova - … Series A: Membrane and Cell Biology, 2022 - Springer
The review considers liposomes as systems of substantial interest as adjuvant carriers in
vaccinology due to their versatility and maximal biocompatibility. Research and …

[HTML][HTML] Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials

CG Rodelo, RA Salinas, EA Jaime, S Armenta… - Coordination Chemistry …, 2022 - Elsevier
Respiratory viruses represent a severe public health risk worldwide, and the research
contribution to tackle the current pandemic caused by the SARS-CoV-2 is one of the main …

Advanced materials for SARS‐CoV‐2 vaccines

MT Mabrouk, WC Huang… - Advanced …, 2022 - Wiley Online Library
The ongoing coronavirus disease 2019 (COVID‐19) pandemic, caused by severe acute
respiratory coronavirus 2 (SARS‐CoV‐2), has killed untold millions worldwide and has …

[HTML][HTML] Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine

JF Lovell, YO Baik, SK Choi, C Lee, JY Lee, K Miura… - BMC medicine, 2022 - Springer
Background Numerous vaccine strategies are being advanced to control SARS-CoV-2, the
cause of the COVID-19 pandemic. EuCorVac-19 (ECV19) is a recombinant protein …

Metal-based nano-vaccines for cancer immunotherapy

J Li, H Ren, Y Zhang - Coordination Chemistry Reviews, 2022 - Elsevier
Cancer vaccination is an effective way to prevent or cure cancers by inducing strong cellular
and humoral immunity with the aid of delivery carriers or adjuvants. Increasing new delivery …

MPLA-adjuvanted liposomes encapsulating S-trimer or RBD or S1, but not S-ECD, elicit robust neutralization against SARS-CoV-2 and variants of concern

J Wang, XG Yin, Y Wen, J Lu, RY Zhang… - Journal of Medicinal …, 2022 - ACS Publications
Safe and effective vaccines are the best method to defeat worldwide SARS-CoV-2 and its
circulating variants. The SARS-CoV-2 S protein and its subunits are the most attractive …

Rational Development of a Polysaccharide–Protein‐Conjugated Nanoparticle Vaccine Against SARS‐CoV‐2 Variants and Streptococcus pneumoniae

Y Deng, J Li, C Sun, H Chi, D Luo, R Wang… - Advanced …, 2022 - Wiley Online Library
The ongoing COVID‐19 pandemic caused by SARS‐CoV‐2 has led to millions of deaths
worldwide. Streptococcus pneumoniae (S. pneumoniae) remains a major cause of mortality …

[HTML][HTML] Intranasal immunization with liposome-displayed receptor-binding domain induces mucosal immunity and protection against SARS-CoV-2

WC Huang, K Chiem, L Martinez-Sobrido, JF Lovell - Pathogens, 2022 - mdpi.com
The global pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), has led to efforts in developing effective vaccine approaches. Currently, approved …

Virus-like particles against infectious disease and cancer: guidance for the nano-architect

RA Hills, M Howarth - Current Opinion in Biotechnology, 2022 - Elsevier
Highlights•Studying VLPs gives important insights into how the immune system makes
decisions.•Spacing antigens using DNA indicates the optimal separation for B cell …